Screener
Protagonist Therapeutics PTGX Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
FAQ
- What is Protagonist Therapeutics's net debt / EBITDA?
- Protagonist Therapeutics (PTGX) reported net debt / EBITDA of -6.9× in Q2 2026.
- How has Protagonist Therapeutics's net debt / EBITDA changed year-over-year?
- Protagonist Therapeutics's net debt / EBITDA decreased by 8.5% year-over-year, from -6.3× to -6.9×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Protagonist Therapeutics's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude